跳至主要内容
临床试验/JPRN-UMIN000041259
JPRN-UMIN000041259已完成未知

Safety-verification trial about excessive intake of test beverage - Safety-verification trial about excessive intake of test beverage

CPCC Company Limited0 个研究点目标入组 16 人开始时间: 2021年8月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects with some kind of continuous medical treatment. (2) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. (3) Subjects who have constantly used the following foods that might affect their blood glucose level, triglyceride level, and intestine-regulating function; health-specific, functional, health foods. (4) Subjects with excessive alcohol intake. (5) Subjects with extremely irregular dietary habits and/or life rhythm. (6) Pregnant or possibly pregnant women, or lactating ones. (7) Subjects with drug and/or food allergy (especially in milk and soybean). (8) Subjects with weak stomach and/or diarrhea-prone constitution. (9) Subjects who are now under the other clinical tests with some kind of medicine/food, or participated those tests within four weeks after this clinical trial. (10) Subjects who donated over 200 mL of their blood and/or blood components within a month to this clinical trial. (11) Males who donated their whole blood (400 mL) within the last three months to this trial. (12) Females who donated their whole blood (400 mL) within the last four months to this trial. (13) Males who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial. (14) Females who will be collected in total of their blood (800 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial. (15) Others who have been determined as ineligible for participation in this trial, according to the principal/sub investigator's opinions.

研究者

发起方
CPCC Company Limited

相似试验